Loading…

Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern Ireland

IntroductionThis study investigated Northern Ireland Diabetic Eye Screening Programme (NIDESP) attendance and diabetic retinopathy (DR) prevalence/severity in patients with diabetes mellitus secondary to chronic pancreatitis (PwDMsCP).Research design and methodsMedical/NIDESP records for all PwDMsCP...

Full description

Saved in:
Bibliographic Details
Published in:BMJ open diabetes research & care 2021-09, Vol.9 (1), p.e002267
Main Authors: Jamison, Catherine, Peto, Tunde, Quinn, Nicola, D’Aloisio, Rossella, Cushley, Laura Nicole, Johnston, Philip C
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b578t-5e85607a018bbb5c336c80ca32ecc2df2e2cc92e49a9afe2729ef7091ead566f3
cites cdi_FETCH-LOGICAL-b578t-5e85607a018bbb5c336c80ca32ecc2df2e2cc92e49a9afe2729ef7091ead566f3
container_end_page
container_issue 1
container_start_page e002267
container_title BMJ open diabetes research & care
container_volume 9
creator Jamison, Catherine
Peto, Tunde
Quinn, Nicola
D’Aloisio, Rossella
Cushley, Laura Nicole
Johnston, Philip C
description IntroductionThis study investigated Northern Ireland Diabetic Eye Screening Programme (NIDESP) attendance and diabetic retinopathy (DR) prevalence/severity in patients with diabetes mellitus secondary to chronic pancreatitis (PwDMsCP).Research design and methodsMedical/NIDESP records for all PwDMsCP attending the pancreatic diabetes clinic were analyzed in 2017 (n=78) and 2019 (n=94).ResultsBetween 2017 and 2019, those without DR decreased (76% to 63%); mild non-proliferative DR (NPDR), severe NPDR and PDR were found in 30%, 2% and 5%, respectively (previously 18%, 4%, 2%); diabetic maculopathy (DMac) was present in 12% (previously 10%). There was no significant difference between worst-eye DR/DMac grade and HbA1c, gender, body mass index, pancreatitis etiology and screening attendance (p>0.05). Patients with proliferative DR had longer diabetes and pancreatitis duration than DR-free patients (both p=0.001).ConclusionsDR prevalence was similar in PwDMsCP and patients with type 2 diabetes of similar disease duration. This work demonstrates the importance of reaching all patients for establishing DR severity reliably and to provide accessible, equitable care to PwDMsCP.
doi_str_mv 10.1136/bmjdrc-2021-002267
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_37041aa67d074f918d9253feab60d98b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_37041aa67d074f918d9253feab60d98b</doaj_id><sourcerecordid>2569941134</sourcerecordid><originalsourceid>FETCH-LOGICAL-b578t-5e85607a018bbb5c336c80ca32ecc2df2e2cc92e49a9afe2729ef7091ead566f3</originalsourceid><addsrcrecordid>eNqNkstuEzEUhkcIRKvSF2BliU2RmOLbjO0NEgq3SOUiLmvL4zmTOJrYqe0E5cl4PZxOVCiLio1tzfn_75w5-qvqKcGXhLD2Zbde9dHWFFNSY0xpKx5UpxQ3tOZSiYd_vU-q85RWGONiI0w2j6sTxrliXPHT6tc3GwG88wtkcgbfG2_hBdpE2JkRyhsZ36MEO4gu71EYUO9MB9lZFMvpw8bk5R5dvPn6HDmPDLJhGWI-CEvFgc8J_XR5ebRBQmsYR5e3qUBtKP3iHuWA7DIGX6Cb0j9CcWaXCvVjmn25AX8q0CVEj-YRxjLSk-rRYMYE58f7rPrx7u332Yf66vP7-ez1Vd01Qua6Adm0WBhMZNd1jWWstRJbwyhYS_uBArVWUeDKKDMAFVTBILAiYPqmbQd2Vs0nbh_MSm-iW5eBdTBO33wIcaFNLNsYQTOBOTGmFT0WfFBE9oo2bADTtbhXsiusVxNrs-3W0NuynGjGO9C7Fe-WehF2WnLKpeAFcHEExHC9hZT12iVb9mk8hG3StBGYifKPTZE--0e6Ctvoy6o0I1wwSRiV96lo0yrFS9QObemksjGkFGG4HZlgfQijnsKoD2HUUxiLqZ5MpfZ_-ss_-tsp7jH8BhEB8W8</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2569941134</pqid></control><display><type>article</type><title>Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern Ireland</title><source>BMJ Open Access Journals</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Jamison, Catherine ; Peto, Tunde ; Quinn, Nicola ; D’Aloisio, Rossella ; Cushley, Laura Nicole ; Johnston, Philip C</creator><creatorcontrib>Jamison, Catherine ; Peto, Tunde ; Quinn, Nicola ; D’Aloisio, Rossella ; Cushley, Laura Nicole ; Johnston, Philip C</creatorcontrib><description>IntroductionThis study investigated Northern Ireland Diabetic Eye Screening Programme (NIDESP) attendance and diabetic retinopathy (DR) prevalence/severity in patients with diabetes mellitus secondary to chronic pancreatitis (PwDMsCP).Research design and methodsMedical/NIDESP records for all PwDMsCP attending the pancreatic diabetes clinic were analyzed in 2017 (n=78) and 2019 (n=94).ResultsBetween 2017 and 2019, those without DR decreased (76% to 63%); mild non-proliferative DR (NPDR), severe NPDR and PDR were found in 30%, 2% and 5%, respectively (previously 18%, 4%, 2%); diabetic maculopathy (DMac) was present in 12% (previously 10%). There was no significant difference between worst-eye DR/DMac grade and HbA1c, gender, body mass index, pancreatitis etiology and screening attendance (p&gt;0.05). Patients with proliferative DR had longer diabetes and pancreatitis duration than DR-free patients (both p=0.001).ConclusionsDR prevalence was similar in PwDMsCP and patients with type 2 diabetes of similar disease duration. This work demonstrates the importance of reaching all patients for establishing DR severity reliably and to provide accessible, equitable care to PwDMsCP.</description><identifier>ISSN: 2052-4897</identifier><identifier>EISSN: 2052-4897</identifier><identifier>DOI: 10.1136/bmjdrc-2021-002267</identifier><identifier>PMID: 34493494</identifier><language>eng</language><publisher>London: American Diabetes Association</publisher><subject>Alcohol ; Body mass index ; Clinical care/Education/Nutrition ; Creatinine ; Diabetes ; diabetes complications ; Diabetic retinopathy ; Disease ; Etiology ; eye diseases ; Gallstones ; Gender ; Nutrition ; pancreas ; Pancreatitis ; Patients ; Quality of life ; Thrombosis</subject><ispartof>BMJ open diabetes research &amp; care, 2021-09, Vol.9 (1), p.e002267</ispartof><rights>Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b578t-5e85607a018bbb5c336c80ca32ecc2df2e2cc92e49a9afe2729ef7091ead566f3</citedby><cites>FETCH-LOGICAL-b578t-5e85607a018bbb5c336c80ca32ecc2df2e2cc92e49a9afe2729ef7091ead566f3</cites><orcidid>0000-0003-0697-8854 ; 0000-0001-6265-0381 ; 0000-0003-1155-1863 ; 0000-0003-0511-8000</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2569941134/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2569941134?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27549,27550,27924,27925,37012,37013,44590,53791,53793,55350,75126,77601,77632,77660,77686</link.rule.ids></links><search><creatorcontrib>Jamison, Catherine</creatorcontrib><creatorcontrib>Peto, Tunde</creatorcontrib><creatorcontrib>Quinn, Nicola</creatorcontrib><creatorcontrib>D’Aloisio, Rossella</creatorcontrib><creatorcontrib>Cushley, Laura Nicole</creatorcontrib><creatorcontrib>Johnston, Philip C</creatorcontrib><title>Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern Ireland</title><title>BMJ open diabetes research &amp; care</title><addtitle>BMJ Open Diab Res Care</addtitle><description>IntroductionThis study investigated Northern Ireland Diabetic Eye Screening Programme (NIDESP) attendance and diabetic retinopathy (DR) prevalence/severity in patients with diabetes mellitus secondary to chronic pancreatitis (PwDMsCP).Research design and methodsMedical/NIDESP records for all PwDMsCP attending the pancreatic diabetes clinic were analyzed in 2017 (n=78) and 2019 (n=94).ResultsBetween 2017 and 2019, those without DR decreased (76% to 63%); mild non-proliferative DR (NPDR), severe NPDR and PDR were found in 30%, 2% and 5%, respectively (previously 18%, 4%, 2%); diabetic maculopathy (DMac) was present in 12% (previously 10%). There was no significant difference between worst-eye DR/DMac grade and HbA1c, gender, body mass index, pancreatitis etiology and screening attendance (p&gt;0.05). Patients with proliferative DR had longer diabetes and pancreatitis duration than DR-free patients (both p=0.001).ConclusionsDR prevalence was similar in PwDMsCP and patients with type 2 diabetes of similar disease duration. This work demonstrates the importance of reaching all patients for establishing DR severity reliably and to provide accessible, equitable care to PwDMsCP.</description><subject>Alcohol</subject><subject>Body mass index</subject><subject>Clinical care/Education/Nutrition</subject><subject>Creatinine</subject><subject>Diabetes</subject><subject>diabetes complications</subject><subject>Diabetic retinopathy</subject><subject>Disease</subject><subject>Etiology</subject><subject>eye diseases</subject><subject>Gallstones</subject><subject>Gender</subject><subject>Nutrition</subject><subject>pancreas</subject><subject>Pancreatitis</subject><subject>Patients</subject><subject>Quality of life</subject><subject>Thrombosis</subject><issn>2052-4897</issn><issn>2052-4897</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>9YT</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkstuEzEUhkcIRKvSF2BliU2RmOLbjO0NEgq3SOUiLmvL4zmTOJrYqe0E5cl4PZxOVCiLio1tzfn_75w5-qvqKcGXhLD2Zbde9dHWFFNSY0xpKx5UpxQ3tOZSiYd_vU-q85RWGONiI0w2j6sTxrliXPHT6tc3GwG88wtkcgbfG2_hBdpE2JkRyhsZ36MEO4gu71EYUO9MB9lZFMvpw8bk5R5dvPn6HDmPDLJhGWI-CEvFgc8J_XR5ebRBQmsYR5e3qUBtKP3iHuWA7DIGX6Cb0j9CcWaXCvVjmn25AX8q0CVEj-YRxjLSk-rRYMYE58f7rPrx7u332Yf66vP7-ez1Vd01Qua6Adm0WBhMZNd1jWWstRJbwyhYS_uBArVWUeDKKDMAFVTBILAiYPqmbQd2Vs0nbh_MSm-iW5eBdTBO33wIcaFNLNsYQTOBOTGmFT0WfFBE9oo2bADTtbhXsiusVxNrs-3W0NuynGjGO9C7Fe-WehF2WnLKpeAFcHEExHC9hZT12iVb9mk8hG3StBGYifKPTZE--0e6Ctvoy6o0I1wwSRiV96lo0yrFS9QObemksjGkFGG4HZlgfQijnsKoD2HUUxiLqZ5MpfZ_-ss_-tsp7jH8BhEB8W8</recordid><startdate>20210907</startdate><enddate>20210907</enddate><creator>Jamison, Catherine</creator><creator>Peto, Tunde</creator><creator>Quinn, Nicola</creator><creator>D’Aloisio, Rossella</creator><creator>Cushley, Laura Nicole</creator><creator>Johnston, Philip C</creator><general>American Diabetes Association</general><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>9YT</scope><scope>ACMMV</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0697-8854</orcidid><orcidid>https://orcid.org/0000-0001-6265-0381</orcidid><orcidid>https://orcid.org/0000-0003-1155-1863</orcidid><orcidid>https://orcid.org/0000-0003-0511-8000</orcidid></search><sort><creationdate>20210907</creationdate><title>Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern Ireland</title><author>Jamison, Catherine ; Peto, Tunde ; Quinn, Nicola ; D’Aloisio, Rossella ; Cushley, Laura Nicole ; Johnston, Philip C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b578t-5e85607a018bbb5c336c80ca32ecc2df2e2cc92e49a9afe2729ef7091ead566f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alcohol</topic><topic>Body mass index</topic><topic>Clinical care/Education/Nutrition</topic><topic>Creatinine</topic><topic>Diabetes</topic><topic>diabetes complications</topic><topic>Diabetic retinopathy</topic><topic>Disease</topic><topic>Etiology</topic><topic>eye diseases</topic><topic>Gallstones</topic><topic>Gender</topic><topic>Nutrition</topic><topic>pancreas</topic><topic>Pancreatitis</topic><topic>Patients</topic><topic>Quality of life</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jamison, Catherine</creatorcontrib><creatorcontrib>Peto, Tunde</creatorcontrib><creatorcontrib>Quinn, Nicola</creatorcontrib><creatorcontrib>D’Aloisio, Rossella</creatorcontrib><creatorcontrib>Cushley, Laura Nicole</creatorcontrib><creatorcontrib>Johnston, Philip C</creatorcontrib><collection>BMJ Open Access Journals</collection><collection>BMJ Journals:Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMJ open diabetes research &amp; care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jamison, Catherine</au><au>Peto, Tunde</au><au>Quinn, Nicola</au><au>D’Aloisio, Rossella</au><au>Cushley, Laura Nicole</au><au>Johnston, Philip C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern Ireland</atitle><jtitle>BMJ open diabetes research &amp; care</jtitle><stitle>BMJ Open Diab Res Care</stitle><date>2021-09-07</date><risdate>2021</risdate><volume>9</volume><issue>1</issue><spage>e002267</spage><pages>e002267-</pages><issn>2052-4897</issn><eissn>2052-4897</eissn><abstract>IntroductionThis study investigated Northern Ireland Diabetic Eye Screening Programme (NIDESP) attendance and diabetic retinopathy (DR) prevalence/severity in patients with diabetes mellitus secondary to chronic pancreatitis (PwDMsCP).Research design and methodsMedical/NIDESP records for all PwDMsCP attending the pancreatic diabetes clinic were analyzed in 2017 (n=78) and 2019 (n=94).ResultsBetween 2017 and 2019, those without DR decreased (76% to 63%); mild non-proliferative DR (NPDR), severe NPDR and PDR were found in 30%, 2% and 5%, respectively (previously 18%, 4%, 2%); diabetic maculopathy (DMac) was present in 12% (previously 10%). There was no significant difference between worst-eye DR/DMac grade and HbA1c, gender, body mass index, pancreatitis etiology and screening attendance (p&gt;0.05). Patients with proliferative DR had longer diabetes and pancreatitis duration than DR-free patients (both p=0.001).ConclusionsDR prevalence was similar in PwDMsCP and patients with type 2 diabetes of similar disease duration. This work demonstrates the importance of reaching all patients for establishing DR severity reliably and to provide accessible, equitable care to PwDMsCP.</abstract><cop>London</cop><pub>American Diabetes Association</pub><pmid>34493494</pmid><doi>10.1136/bmjdrc-2021-002267</doi><orcidid>https://orcid.org/0000-0003-0697-8854</orcidid><orcidid>https://orcid.org/0000-0001-6265-0381</orcidid><orcidid>https://orcid.org/0000-0003-1155-1863</orcidid><orcidid>https://orcid.org/0000-0003-0511-8000</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2052-4897
ispartof BMJ open diabetes research & care, 2021-09, Vol.9 (1), p.e002267
issn 2052-4897
2052-4897
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_37041aa67d074f918d9253feab60d98b
source BMJ Open Access Journals; Publicly Available Content Database; PubMed Central
subjects Alcohol
Body mass index
Clinical care/Education/Nutrition
Creatinine
Diabetes
diabetes complications
Diabetic retinopathy
Disease
Etiology
eye diseases
Gallstones
Gender
Nutrition
pancreas
Pancreatitis
Patients
Quality of life
Thrombosis
title Screening attendance, prevalence and severity of diabetic retinopathy (DR) in a cohort of patients with diabetes mellitus secondary to chronic pancreatitis (DMsCP) in Northern Ireland
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A04%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Screening%20attendance,%20prevalence%20and%20severity%20of%20diabetic%20retinopathy%20(DR)%20in%20a%20cohort%20of%20patients%20with%20diabetes%20mellitus%20secondary%20to%20chronic%20pancreatitis%20(DMsCP)%20in%20Northern%20Ireland&rft.jtitle=BMJ%20open%20diabetes%20research%20&%20care&rft.au=Jamison,%20Catherine&rft.date=2021-09-07&rft.volume=9&rft.issue=1&rft.spage=e002267&rft.pages=e002267-&rft.issn=2052-4897&rft.eissn=2052-4897&rft_id=info:doi/10.1136/bmjdrc-2021-002267&rft_dat=%3Cproquest_doaj_%3E2569941134%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b578t-5e85607a018bbb5c336c80ca32ecc2df2e2cc92e49a9afe2729ef7091ead566f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2569941134&rft_id=info:pmid/34493494&rfr_iscdi=true